Urrutia-Torres F, Barragán-Pérez E, Espinosa-Islas G, Pierdant M, Hernández-Hernández M, Capistro-Hurtado F, Huerta-Huerta A, Guerra-Molina D, Santana-García F, Espinoza-Monteros R, Hernández-Aguilar J, Garza-Morales S

Language: Spanish
References: 27
Page: 389-394
PDF size: 51.74 Kb.

ABSTRACT

Introduction. Because the patency of foramen ovale in adult patients with migraine has been detected to have association with vascular events, we think it is of great importance to detect this cardiovascular anomaly in children with the diagnosis of migraine and prevent secondary complications. Objective: Determine the prevalence of patent foramen ovale in pediatric patients with migraine.
Material and methods. Children diagnosed with migraine (with or without aura) according to the criteria of the International Headache Society seen during the period between November 2005 and June 2006 in the Department of Pediatric Neurology at the Hospital Infantil de Mexico Federico Gomez were enrolled and a bidimensional Doppler echocardiogram was performed looking for the persistence of foramen ovale.
Results. We included 40 patients with ages ranging between 5 to 17 years, 57% were girls and 42% presented migraine with aura. Based on the time of evolution our study group was stratified as follows: 16% less than a year, 35% 1 year, 25% 2 years, 17% 3 years and 7% 5 years. We found no association between gender and a specific type of migraine. We found patency of foramen ovale in 11 patients (27.5%), 5 females and 6 males; 9 (81.8%) patients presented migraine with aura and 2 (18.1%) without aura.
Conclusion. We found a high prevalence of patent foramen ovale in patients with migraine with aura. From 17 patients in our study group with diagnosis of migraine with aura; 9 of them (52%) had ultrasonographic finding of patency of the foramen.

REFERENCES

1. Headache Classification Committee of the International Headache Society. Classification and Diagnostic Criteria for Headache disorders, cranial neuralgias and facial pain. Cephalalgia. 2004; 24 Supl 1: 1-160.

2. Maytal J, Young M, Shechter BA, Lipton RB. Pediatric migraine and the International Headache Society (IHS) criteria. Neurology. 1997; 48: 602.

3. Lipton RB, Bigal ME, Steiner TJ, Silberstein SD, Olsen J. The classification of the headaches. Neurology. 2004; 63: 427-35.

4. Kenneth S, Sthepen A. Pediatric neurology: Principles & practice. Fourth ed. Philadelphia: PA, Mosby; 2006. p. 747-58.

5. Fenichel GM. Clinical Pediatric Neurology. A signs and symptoms approach. Fifth ed. Philadelphia: PA, Elsevier Saunders; 2005.

6. Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med. 2005; 118 Suppl 1: 3-10S.

7. Welch KMA, D´Andrea G, Tepley N, Barkley GL. The concept of migraine as a state of central neuronal hyperexcitability. Headache. 1990; 8: 817-28.

8. Aurora SK, Ahmad BK, Welch KMA, Bhradhwaj P, Ramadan NM. Transcranial magnetic stimulation confirms hiperexcitability of occipital cortex in migraine. Neurology. 1998; 50: 1111-4.

9. Lauritzen M. Pathophysiology of the migraine aura: The spreading depression theory. Brain. 1994; 117: 199-210.

10. Lauritzen M. Cortical spreading depression in migraine. Cephalalgia. 2001; 21: 757-60.

11. Battelli L, Black KR, Wray SH. Transcranial magnetic stimulation of visual area V5 in migraine. Neurology. 2002; 58: 1066-9.

12. Lears E, Rolf U. Neurobiology in primary headaches. Brain Res Rev. 2005; 48: 438-56.

13. Stephen DS. Migraine. Lancet. 2004; 363: 381-91.

14. Waeber C, Moskowitz MA. Therapeutic implications of central and peripheral neurologic mechanisms in migraine. Neurology. 2003; 61 Supl 4: 9-S20.

15. Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology. 2005; 64 Supl 2: 9-S15.

16. Tzourio C, Tehindrazanarivelo A, Iglesias S, Alperovitch A, Chedru FA. Case-control study of migraine and risk of ischemic stroke in young women. BMJ. 1995; 310: 830-3.

17. Del Sette M, Angeli S, Lenadri M, Ferreiro G, Bruzzone L, Finocchi C. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis. 1998; 8: 327-30.

18. Anzola GP, Mangoni M, Guindani AC. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology. 1999; 52: 1622-5.

19. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci. 2001; 100: 215-20.

20. Sztajzel R, Geround D, Roth S, Mermillod B, Le Floch R Jr. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis. 2002; 13: 102-6.

21. Wilmshurst P, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for hemodynamic reasons. Lancet. 2000; 356: 1648-51.

22. Morandi E, Anzola GP, Angeli S, Castelli F, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Inter Cardiol. 2003; 16: 38-42.

23. Schwerzmann M, Wiher S, Nedeltchev K, Lagger M, Mattle B, Windecker D. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology. 2004; 62: 1399-401.

24. Yankovsky AE, Kuritzki A. Transformation into daily migraine with aura following transcutaneous atrial septal defect clouse. Headache. 2003; 42: 496-8.

25. Schwerzmann M, Wiher S, Nedeltchev K, Meyer B, Seiler C. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology. 2005; 65: 1415-8.

26. Reisman M, Christofferson RD, Jerusum J, Olsen JV, Spencer M, Krabill K, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am College Cardiol. 2005; 45: 493-5.

27. Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology. 2004; 62: 1439-40.